Listen Top Shows Blog

Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform

Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform

Update: 2025-11-24

Share

Description

About this podcast:
This podcast comes from the DPHARM 2025 meeting. Pfizer details how they jointly co-designed and implemented an EDC/CDMS platform that’s fit for purpose, and analysis data set. This session focuses on:

Engaging all stakeholders in designing the platform
The evolution of the platform focus: the transition from the majority of data coming from EDC to 3/4 of the data from third party sources
Impact of the advanced data analysis capabilities for risk management
Review of impact on initial studies now using the platform

For more information, go to DPHARMconference.com.

Comments

In Channel

Building Up a CMO Team as Your Company Evolves

Building Up a CMO Team as Your Company Evolves

2025-12-0132:20

Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles

Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles

2025-12-0129:52

Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform

Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform

2025-11-2415:26

Insights from Tufts CSDD into Evolving Trial Partnerships Models

Insights from Tufts CSDD into Evolving Trial Partnerships Models

2025-11-2416:05

ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma

ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma

2025-11-2419:18

Understanding the Immunological Effects of Radiopharmaceuticals

Understanding the Immunological Effects of Radiopharmaceuticals

2025-11-2418:11

How J&J Is Integrating Patient Centricity Across the Enterprise

How J&J Is Integrating Patient Centricity Across the Enterprise

2025-11-1926:00

Biogen's Nicole Murphy on Drug Delivery Innovation and the Acquisition of Alcyone Therapeutics

Biogen's Nicole Murphy on Drug Delivery Innovation and the Acquisition of Alcyone Therapeutics

2025-11-1931:13

What to Expect at the 2026 IO360° Summit

What to Expect at the 2026 IO360° Summit

2025-11-1204:22

CMOs Working Flexibly with Consultants and Fractional Expertise

CMOs Working Flexibly with Consultants and Fractional Expertise

2025-11-0330:55

Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

2025-10-2417:35

How Patient Organizations are Bridging Patient Inclusivity Gaps at the Site-Level

How Patient Organizations are Bridging Patient Inclusivity Gaps at the Site-Level

2025-10-2441:58

How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost

How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost

2025-10-2113:08

How to Embed Clinical Research in Rural and Frontier Health Systems

How to Embed Clinical Research in Rural and Frontier Health Systems

2025-10-2119:11

Optimizing the Value Proposition in Small Companies with Limited Budgets

Optimizing the Value Proposition in Small Companies with Limited Budgets

2025-09-3030:13

From the DPHARM 2024 Archives: Biogen Pilot on Using Vocal Biomarkers to Identify Potential Participants for Clinical Trials

From the DPHARM 2024 Archives: Biogen Pilot on Using Vocal Biomarkers to Identify Potential Participants for Clinical Trials

2025-09-2621:09

Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement

Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement

2025-09-2618:44

Ensuring Continuity in Patient Insights to Strengthen Medicine Development

Ensuring Continuity in Patient Insights to Strengthen Medicine Development

2025-08-2218:22

Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach

Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach

2025-08-2216:16

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

2025-08-1428:59

00:00

00:00

x

Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform

Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform

Conference Forum